The GreenLight Clinical team is established and run by a group of highly-regarded physicians and researchers with a multi-disciplinary skillset, and a proven track record in delivering high-quality research output to our clients.
Our staff of experienced, knowledgeable clinical trial professionals aims to provide the highest quality research outcomes for our partners, and as a full-service provider, our teams cover all aspects of clinical trial management, drug & device development, and global regulatory affairs.
Led by Passionate Experts
Medical Affairs & Communications Director
Equipped with a strong background in academic and translational research, Sam has worked with numerous emerging pharma and biotech companies over the past 15 years to bring their novel therapeutics to the marketplace.
Holding a PhD in retinal vascular biology from the University of Sydney, Sam has worked in diverse roles in the clinical research industry, from preclinical study design & execution, clinical monitoring, business development, and medical liaison management.
Having been with GreenLight Clinical since 2016, Sam has spearheaded numerous developments in medical outreach for the company, building a wide-ranging, experienced, and agile Medical Affairs team, able to rapidly pivot to sponsors’ needs and respond to changing market forces. Dovetailing with our core service teams, Sam and his team are the conduits to our clinical service and analytic divisions, with broad knowledge and a can-do attitude, driving positive outcomes for our clients and sponsors.
Focusing on growing global markets, Sam leads a team of Medical Science Liaisons, Medical Writers, Preclinical Experts, and Technical & Proposal Specialists to ensure that programs managed by GreenLight Clinical are scientifically sound, fit-for-purpose, and will bring the safest possible products to market in the shortest possible time.
B.Sc (Hons), M.Stat, PhD
Dr. Pardy has 12 years of experience in medical statistics, beginning as a biostatistician for the NHMRC Clinical Trials Centre in Australia where he rose to be Head of Methodological Development within the biostatistics team. He has diverse experience within biomedical research including biostatistical methodology (e.g., adjusted analysis in the presence of broken randomisation schemes, effect size prediction for primary endpoints based on surrogate endpoints), gene expression data mining, analysis of large public health datasets, and bioinformatics. He has spent substantial time working as an independent statistical consultant in both academia and industry and has also worked as part of an established statistical consulting group within the University of New South Wales (UNSW). He has consulted for a range of fields from business and finance to biomedical research at the lab level through observational studies of medical records data to large-scale prospective clinical research. His clinical trial experience includes the design and analysis of trials for all phases from small early phase studies to multinational randomized Phase IV studies with over 10,000 subjects. Dr. Pardy has more than 750 academic citations for clinical trial work in cardiovascular disease and diabetes, and his teaching experience includes postgraduate courses on Biostatistics and Clinical Trial methodology. Dr. Pardy has a PhD in Statistical Genetics from the Prince of Wales Hospital Clinical School (UNSW), MStat, and BSc (Hons) (Statistics).
Global Clinical Operations Director
With a background as a Registered Nurse, Carole moved into the industry over 20 years ago. Carole has worked in a hospital setting, in Pharmaceutical companies and Contract Research Organisations.
With over 12 years’ experience in leadership, she’s managed large teams and been involved in project management, quality management, site management, and patient recruitment. She also brings a wealth of therapeutic area experience including cardiovascular, oncology, immunology, endocrinology, respiratory, psychiatry, and neurology.
Companies Carole has worked for include Covance, Merck Serono, Quintiles, Icon, Sanofi-Aventis, and Agenus where she had the stewardship of multiple CROs.
Group Laboratory Manager
Justine Miller is a qualified Medical Laboratory Scientist with over 25 years’ experience in the pathology industry.
Justine started her career as a multi-skilled scientist in small stat laboratories attached to private hospitals. Through career progression, Justine moved into the public hospital sector as a senior scientist, before coming back to private pathology for a large throughput laboratory company as a QC/QA officer performing internal audits at peripheral and regional laboratories. Through these years, Justine obtained skills in Biochemistry, Haematology, Morphology, Blood Banking, Coagulation, Microbiology, Veterinary Pathology, Training, Auditing, Manual Sample processing, Specimen Reception and Shipping.
In 2012 Justine moved into a Laboratory Management position for a dedicated Clinical Trials laboratory in Sydney. During this time, Justine has gained a lot of insight and experience within the Clinical Trials industry and is experienced in GCP, GCLP, NATA and NPAAC requirements for Medical Laboratories, Quality Management Systems, handing dangerous goods and external audits.
Through her many years’ experience in diagnostic pathology and clinical trials, Justine understands the strict requirements needed for clinical trials and the rigour needed in order the produce good quality data for clinical trials submission. Justine is dedicated to ensuring this quality of service.
Some previous companies that Justine has worked with are Mayne Health, Laverty Pathology, Gribbles Pathology, Westmead Hospital ICPMR, Sonic Healthcare.
Dr Navapun Charuruks
Global Laboratory Services Director
MD, FRCPath (Thailand)
Navapun Charuruks is a professor in Clinical Pathology who started her career as a lecturer at Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University where she gained experience and developed her professional career as the Head of Department of Laboratory Medicine and had earned the position of Professor in Clinical Pathology. The laboratory under the Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University had been the first laboratory in Asia to achieve ISO 15189 in April 2004. Her last position at Chulalongkorn University was the Vice Dean of College of Public Health and the Deputy Director of Chulalongkorn University Research Centre. She had been invited to join Laboratory Division, Bumrungrad International Hospital as the consultant in 2007 and posted as the Director in 2012-2017. The Laboratory Division, Bumrungrad International Hospital has been the first private and clinical service laboratory in Thailand to achieve CAP in 2016. She has been invited to take the position of Quality Consultant at the National Blood Centre, Thai Red Cross, Bangkok, Thailand since 2018. Her current position in GreenLight Clinical is Laboratory Director at GreenLight Clinical Laboratory, Bangkok, Thailand.
Director of Project Implementation
Lesley brings over 20 years of experience in patient recruitment, advocacy and retention at world leading pharmaceutical and medical device companies including Abbvie, Abbott, Sanofi Aventis, Astra Zeneca and Eli Lilly.
At Greenlight, we see giving patients access to new medications form part of our overall mission to be part of discoveries that change lives. Retention of these patients on trial and wider patient advocacy is core to everything we do – it’s people that drive our business.
Lesley ensures that we access and recruit qualified patients, and retain them for the duration of the trials, as well as increase awareness of our trials to drive the best possible research outcomes. Our processes are highly targeted, transparent and consistent meaning that we are able to support the research outcomes in the shortest possible time whilst giving our patients access to cutting edge treatments.
Group General Counsel,
Compliance & Risk
Franz D’Lima has over 20 years of experience as a senior corporate lawyer and general counsel in global FMCG, healthcare, and B2B industries. His diverse experience in ANZ, EMEA, and APAC (including emerging markets such as China and India), has helped him develop an acute understanding of the legal environment in multiple jurisdictions as well as an appreciation of cross-cultural sensitivities.
Franz approaches legal issues from a commercial perspective and has acquired a reputation as a trusted business partner. He has managed a number of complex projects including the successful transition of a US$100M healthcare business in Japan, the divestment of multi-million dollar cigarette paper businesses in Indonesia, and the Philippines, and established manufacturing facilities and R&D centres across the Asia Pacific region.
Franz has successfully led and defended multifaceted legal actions against the government and quasi-government agencies most notably in China, Korea, the Philippines, and Thailand.
Franz is a qualified lawyer in both England & Wales, and New South Wales, Australia and specialises in M&A, divestments, strategic alliances, intellectual property, data privacy, anti-bribery, risk and compliance management.
Global People and Culture Manager
Kathia has accumulated 10 years’ experience in human resources and currently holds the role of Global People and Culture Director. Having held HR roles within the mining and not-for-profit international companies, she is very familiar with the full employee lifecycle in an organisation.
Kathia is people orientated and her passion lies with striving to ensure wellbeing and cohesion within the company, whilst ensuring compliance with relevant workplace legislation laws and regulations. Kathia provides coaching, advice to Line Managers, manages HR staff in Thailand and the U.S., and is proactive in nurturing the culture and a positive working environment.